Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies
ConclusionsIn line with previous meta-analyses, we observed a small but statistically significant association between ever (vs. never) use of pioglitazone and bladder cancer risk; however, causality is not established and alternative explanations cannot be ruled out.
Source: Diabetology International - Category: Endocrinology Source Type: research
More News: Actos | Bladder Cancer | Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Statistics | Study